Toxic epidermal necrolysis: Difference between revisions

Of note, this scoring system is most valuable when used on the first and 3rd day of hospitalization, and it may underestimate mortality in patients with respiratory symptoms. <ref>{{cite journal|last=DeMers|first=G|coauthors=Meurer, WJ; Shih, R; Rosenbaum, S; Vilke, GM|title=Tissue plasminogen activator and stroke: review of the literature for the clinician.|journal=The Journal of emergency medicine|date=2012 Dec|volume=43|issue=6|pages=1149-54|pmid=22818644}}</ref>

 

 

Those who survive the acute phase of TEN are often suffer longterm complications affecting the skin and eyes. Skin manifestations can include scarring, eruptive [[melanocytic nevi]], [[vulvovaginal stenosis]], and [[dyspareunia]]. Ocular symptoms are the most common complication in TEN, experienced by 20-79% of those with TEN, even by those who d not experience immediate ocular manifestations. These can can include [[dry eyes]], [[photophobia]], [[symblepharon]], corneal scarring or [[xerosis]], subconjunctival fibrosis, [[trichiasis]], decreased visual acuity, and blindness.